浅析药物制剂专利在我国面临的间接侵权困境

Analysis of the Indirect Infringement Dilemma of Pharmaceutical Preparation Patents in China

新冠病毒的流行和随之而来的药品专利问题,在2020年初引起了社会各界的关注。专利制度的根本目的在于保护创新成果从而推动社会进步,在公众健康和医疗卫生领域中,专利制度保留了充分的人文关怀。而另一方面,为更好的保护专利权人的合法利益,专利制度也扩展了间接侵权的概念。但在药物制剂领域中,专利制度的人文关怀和间接侵权将会发生冲突,此时,对药物制剂专利的保护,会变得进退维谷。

In early 2020, the prevalence of the COVID-2019 and the consequent problems of pharmaceutical patent have become pop topics in the society. The fundamental purpose of the patent system is to encourage innovation and promote social progress. While in the fields of public health and medical care, the patent system reserves enough humanistic care. On the other hand, in order to protect the patentees’ legal advantages better, the patent system has also expanded to the field of indirect infringement. However, in the technical field of pharmaceutical preparation, when the humanistic care and indirect infringement conflict with each other, the protection of pharmaceutical preparation patent will become a dilemma.